Health & Fitness
Health and Fitness
Health and Fitness
Sat, January 31, 2009Fri, January 30, 2009Thu, January 29, 2009Wed, January 28, 2009Tue, January 27, 2009Mon, January 26, 2009Sun, January 25, 2009Fri, January 23, 2009Thu, January 22, 2009Wed, January 21, 2009Tue, January 20, 2009Mon, January 19, 2009Fri, January 16, 2009Thu, January 15, 2009Wed, January 14, 2009Tue, January 13, 2009Sepracor Inc. Sets Conference Call and Webcast for Fourth Quarter and Full-Year 2008 Operating Results
Published in Health and Fitness on Friday, January 23rd 2009 at 13:20 GMT, Last Modified on 2009-01-23 13:20:45 by Market Wire
MARLBOROUGH, Mass.--([ BUSINESS WIRE ])--Sepracor Inc. (Nasdaq: SEPR) will issue a press release of its fourth quarter and full-year 2008 financial results after the markets close on January 28, 2009. Sepracor will host a conference call and live webcast beginning at 8:30 a.m. ET on January 29, 2009 to discuss its fourth quarter and full-year 2008 financial results.
To participate via telephone, dial (651) 291-0900 and refer to conference identification number 982103. Please call ten minutes prior to the scheduled conference call time.
For live webcasting, go to the Sepracor web site at [ www.sepracor.com ] and access the For Investors section. Click on either the live webcast link or microphone icon to listen. Please go to the web site at least 15 minutes prior to the call in order to register, download, and install any necessary software.
A PDF file of the slides will also be made available in the For Investors section of the web site just prior to the commencement of the webcast.
A replay of the call will be accessible by telephone after completion of the live call and will be available for approximately one week. To replay the call, dial (320) 365-3844 using access code 982103.
Sepracor Inc. is a research-based pharmaceutical company dedicated to treating and preventing human disease by discovering, developing and commercializing innovative pharmaceutical products that are directed toward serving large and growing markets and unmet medical needs. Sepracor's drug development program has yielded a portfolio of pharmaceutical products and candidates with a focus on respiratory and central nervous system disorders. Sepracor's corporate headquarters are located in Marlborough, Massachusetts.
For a copy of this release or any recent release, visit [ www.sepracor.com ].
